Expression of Egr-1 in late stage emphysema.
Expression of Egr-1 in late stage emphysema.
复制标题
DOI:
10.1016/s0002-9440(10)64646-9
复制
发表时间:
2000-10
期刊:
影响因子:
--
通讯作者:
Weisu Zhang;S. Yan;Aiping Zhu;Y. Zou;Matthew R. Williams;G. Godman;B. Thomashow;M. Ginsburg;David M. Stern;S. Yan
中科院分区:
文献类型:
--
作者:
Weisu Zhang;S. Yan;Aiping Zhu;Y. Zou;Matthew R. Williams;G. Godman;B. Thomashow;M. Ginsburg;David M. Stern;S. Yan
The transcription factor early growth response (Egr)-1 is an immediate-early gene product rapidly and transiently expressed after acute tissue injury. In contrast, in this report we demonstrate that lung tissue from patients undergoing lung reduction surgery for advanced emphysema, without clinical or anatomical evidence of acute infection, displays a selective and apparently sustained increase in Egr-1 transcripts and antigen, compared with a broad survey of other genes, including the transcription factor Sp1, whose levels were not significantly altered. Enhanced Egr-1 expression was especially evident in smooth muscle cells of bronchial and vascular walls, in alveolar macrophages, and some vascular endothelium. Gel shift analysis with32P-labeled Egr probe showed a band with nuclear extracts from emphysematous lung which was supershifted with antibody to Egr-1. Egr-1 has the capacity to regulate genes relevant to the pathophysiology of emphysema, namely those related to extracellular matrix formation and remodeling, thrombogenesis, and those encoding cytokines/chemokines and growth factors. Thus, we propose that further analysis of Egr-1, which appears to be up-regulated in a sustained fashion in patients with late stage emphysema, may provide insights into the pathogenesis of this destructive pulmonary disease, as well as a new facet in the biology of Egr-1.